Back to MA Mirae Asset Global Investments Co., Ltd.
CRDL
Showing 0 of 7 quarters
Position history for MAMirae Asset Global Investments Co., Ltd.'s holdings in Cardiol Therapeutics Inc.
No. Mirae Asset Global Investments exited its CRDL (Cardiol Therapeutics) position in Q1 2023. Its Q4 2022 13F listed 1,094,040 shares worth $557,133. Mirae Asset Global Investments first reported CRDL in Q3 2021 and held it in 6 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of CRDL: Citadel Advisors LLC, Verition Fund Management LLC, Renaissance Technologies LLC, Two Sigma Investments, LP